CPMG Inc, Director, 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 1,200,000 shares at $25.00 ($30.0M) on 2017-06-22, disclosed to the SEC on 2017-06-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.00 | 33,656 | $841K | 2.8% |
| 2 | $25.00 | 102,120 | $2.6M | 8.5% |
| 3 | $25.00 | 110,640 | $2.8M | 9.2% |
| 4 | $25.00 | 211,708 | $5.3M | 17.6% |
| 5 | $25.00 | 355,591 | $8.9M | 29.6% |
| 6 | $25.00 | 386,285 |
| $9.7M |
| 32.2% |
| Total | $25.00 avg | 1,200,000 | $30.0M | 100% |
| Filing → |
| RETA | BUY | 2019-11-18 | $7.4M | — | Filing → |
| RETA | BUY | 2018-12-12 | $13.2M | — | Filing → |
| RETA | BUY | 2017-12-29 | $484K | — | Filing → |